Gagnon R F, Obst G, Richards G K, Gervais F
Montreal General Hospital, McGill University, Que., Canada.
Nephron. 1990;56(2):201-5. doi: 10.1159/000186133.
Peritoneal dialysis (PD) solutions and therapeutic drugs frequently added to PD solutions in clinical practice have been shown to reduce the viability and to impair the function of mouse peritoneal cells. The cytotoxicity of PD solutions, directly related to the dextrose concentration, was more marked towards resident than elicited peritoneal cells. None of the drug additives, heparin and insulin amongst them, were cytotoxic when tested alone or combined with 4.25% PD solution, with the exception of phosphatidylcholine which markedly enhanced the cytotoxicity of the PD solution. While the function of mouse peritoneal macrophages as measured by their hydrogen peroxide production was largely unaffected by PD solutions and drug additives when tested separately, the combination of 4.25% PD solution with any of the drug additives resulted in complete abolition of macrophage respiratory burst. The results should caution against the indiscriminate addition of drugs to PD solutions in dialysis patients.
腹膜透析(PD)溶液以及临床实践中经常添加到PD溶液中的治疗药物已被证明会降低小鼠腹膜细胞的活力并损害其功能。PD溶液的细胞毒性与葡萄糖浓度直接相关,对常驻腹膜细胞的影响比对诱导腹膜细胞的影响更明显。在单独测试或与4.25%的PD溶液联合测试时,包括肝素和胰岛素在内的药物添加剂均无细胞毒性,但磷脂酰胆碱除外,它会显著增强PD溶液的细胞毒性。虽然单独测试时,PD溶液和药物添加剂对小鼠腹膜巨噬细胞过氧化氢产生所测量的功能影响不大,但4.25%的PD溶液与任何一种药物添加剂联合使用都会导致巨噬细胞呼吸爆发完全消失。这些结果应提醒人们注意,不要在透析患者的PD溶液中随意添加药物。